FI3634581T3 - Koostumuksia käytettäväksi synnynnäisen ripulihäiriön hoidossa - Google Patents

Koostumuksia käytettäväksi synnynnäisen ripulihäiriön hoidossa Download PDF

Info

Publication number
FI3634581T3
FI3634581T3 FIEP18810153.9T FI18810153T FI3634581T3 FI 3634581 T3 FI3634581 T3 FI 3634581T3 FI 18810153 T FI18810153 T FI 18810153T FI 3634581 T3 FI3634581 T3 FI 3634581T3
Authority
FI
Finland
Prior art keywords
given
composition
giving
twice
day
Prior art date
Application number
FIEP18810153.9T
Other languages
English (en)
Finnish (fi)
Inventor
Lisa Conte
Pravin Chaturvedi
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Application granted granted Critical
Publication of FI3634581T3 publication Critical patent/FI3634581T3/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
FIEP18810153.9T 2017-05-31 2018-05-31 Koostumuksia käytettäväksi synnynnäisen ripulihäiriön hoidossa FI3634581T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762513251P 2017-05-31 2017-05-31
PCT/US2018/035468 WO2018222919A1 (en) 2017-05-31 2018-05-31 Methods and compositions for treating congenital diarrhea disorder

Publications (1)

Publication Number Publication Date
FI3634581T3 true FI3634581T3 (fi) 2024-08-16

Family

ID=64455032

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP18810153.9T FI3634581T3 (fi) 2017-05-31 2018-05-31 Koostumuksia käytettäväksi synnynnäisen ripulihäiriön hoidossa

Country Status (12)

Country Link
US (2) US11857510B2 (https=)
EP (1) EP3634581B8 (https=)
JP (1) JP2020525407A (https=)
CN (1) CN110831667A (https=)
AU (1) AU2018278312B2 (https=)
CA (1) CA3065797A1 (https=)
DK (1) DK3634581T3 (https=)
ES (1) ES2988850T3 (https=)
FI (1) FI3634581T3 (https=)
IL (1) IL270984B1 (https=)
JO (1) JOP20190275B1 (https=)
WO (1) WO2018222919A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190276B1 (ar) 2017-05-31 2024-04-18 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275B1 (ar) 2017-05-31 2024-12-22 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
MX2022016367A (es) * 2020-06-19 2023-01-30 Napo Pharmaceuticals Inc Metodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0214317B1 (fr) 1985-08-30 1988-08-17 Societe Des Produits Nestle S.A. Produit diététique à activité dépurative et anti-diarrhéique et son procédé de préparation
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
SI9011933A (sl) 1990-10-15 1998-06-30 TANIN SEVNICA Kemična industrija p.o. Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba
EP0935417B1 (en) * 1996-10-16 2009-05-06 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
CA2657803C (en) 2006-05-01 2019-01-08 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
SG195538A1 (en) 2006-05-01 2013-12-30 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
AU2010303577B2 (en) * 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
EP2632550B1 (en) 2010-10-31 2017-05-03 Napo Pharmaceuticals, Inc. Methods and compositions for treating hiv-associated diarrhea
EP3393460A4 (en) 2015-12-23 2019-09-25 Vanessa Research, Inc. COMPOSITIONS AND METHODS FOR TREATING MVID AND RELATED DISEASES
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190275B1 (ar) 2017-05-31 2024-12-22 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JOP20190276B1 (ar) 2017-05-31 2024-04-18 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة

Also Published As

Publication number Publication date
CA3065797A1 (en) 2018-12-06
EP3634581B8 (en) 2024-09-11
JP2020525407A (ja) 2020-08-27
WO2018222919A1 (en) 2018-12-06
US20240325346A1 (en) 2024-10-03
EP3634581A1 (en) 2020-04-15
US20200108047A1 (en) 2020-04-09
ES2988850T3 (es) 2024-11-21
DK3634581T3 (da) 2024-08-26
JOP20190275B1 (ar) 2024-12-22
AU2018278312A1 (en) 2020-01-02
IL270984A (en) 2020-01-30
US11857510B2 (en) 2024-01-02
AU2018278312B2 (en) 2024-07-04
IL270984B1 (en) 2026-01-01
EP3634581A4 (en) 2021-02-24
EP3634581B1 (en) 2024-07-31
CN110831667A (zh) 2020-02-21
JOP20190275A1 (ar) 2019-11-27

Similar Documents

Publication Publication Date Title
FI3634581T3 (fi) Koostumuksia käytettäväksi synnynnäisen ripulihäiriön hoidossa
Zheng et al. An Early Cretaceous heterodontosaurid dinosaur with filamentous integumentary structures
Kotler Owl predation on desert rodents which differ in morphology and behavior
Čerňanský et al. Fossil lizard from central Europe resolves the origin of large body size and herbivory in giant Canary Island lacertids
Marmi et al. The Molí del Baró-1 site, a diverse fossil assemblage from the uppermost Maastrichtian of the southern Pyrenees (north-eastern Iberia)
BRPI0414918A (pt) compostos de benzoimidazola
BR0011858A (pt) Composição antimicrobiana
DE69811981D1 (de) Chitosan enthaltende Zusammensetzung zur Erhöhung der Widerstandskraft gegen Pflanzenkrankheiten
BG100795A (en) The use of codliver oil for plant protection
BR0015538B1 (pt) emprego de polissiloxanos com grupos amino quaternÁrios como coadjuvantes de formulaÇço, agentes contendo-os, bem como tubos de polipropileno de dose énica contendo os referidos agentes.
Liu et al. Are clonal plants more tolerant to grazing than co-occurring non-clonal plants in inland dunes?
Boro et al. New records of bats (Mammalia: Chiroptera) from Assam, northeastern India with a distribution list of bat fauna of the state
González-Muñoz et al. Establishment success of coexisting native and exotic trees under an experimental gradient of irradiance and soil moisture
RU2006101152A (ru) Покрытые семена и способ нанесения покрытий на семена
Mugisha et al. First observation of Dorylus ant feeding in Budongo chimpanzees supports absence of stick-tool culture
Hedderson et al. Phylogenetic relationships of the Wardiaceae (Musci); evidence from 18s rRNA and rps4 gene sequences
ATE198352T1 (de) Oligonukleotide spezifisch für humane papillomaviren
Coriolano et al. Anatomy and functional architecture of the anconeus muscle
Eagderi et al. Head morphology of the duckbill eel, Hoplunnis punctata (Regan, 1915; Nettastomatidae: Anguilliformes) in relation to jaw elongation
FR2891993B1 (fr) Composition pour application phytopharmaceutique pour stimuler les defenses naturelles des plantes
Javid et al. Recent record of least Pipistrelle (Pipistrellus tenuis)(Vespertilionidae: Chiroptera) from Islamabad.
Taszakowski Notes on the occurrence of Gampsocoris Fuss, 1852 (Hemiptera: Heteroptera: Berytidae) in Poland
Jaeger Martensopoda gen. nov. from southern Indian mountain ranges, the first genus of huntsman spiders with a cymbial spur (Araneae: Sparassidae: Heteropodinae)
Bala Population fluctuation of yellow mite, Polyphagotarsonemus latus,(Bank)(Acari: Tarsonemidae) infesting chilli and its management in West Bengal
Iholkina et al. Public policy for supporting innovation in the field of ecology and healthcare (the case of Israel)